首页> 美国卫生研究院文献>other >Efficacy and safety of Yinchen Sini decoction in treating biliary atresia patients after Kasai portoenterostomy
【2h】

Efficacy and safety of Yinchen Sini decoction in treating biliary atresia patients after Kasai portoenterostomy

机译:茵陈四逆汤治疗Kasai腔肠造口术后胆道闭锁的疗效及安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Biliary atresia (BA) is a neonatal obstructive biliary tract disease in which the intrahepatic and extrahepatic bile ducts are obstructed and can lead to congenital biliary atresia of cholestatic cirrhosis and eventually liver failure. It has been confirmed that the Kasai portoenterostomy is an effective treatment for BA. But most patients still face complications, such as cholangitis and liver fibrosis. Yinchen Sini decoction (YCSND), a traditional herbal formula, is used as a treatment for BA after Kasai portoenterostomy. And it is supported that YCSND can improve jaundice and liver fibrosis through multiple targets and pathways. Based on the published literature, this study aims to evaluate the current situation in the treatment of BA in children with YCSND.
机译:背景:胆道闭锁症(BA)是一种新生儿阻塞性胆道疾病,其中肝内和肝外胆管受阻,可导致胆汁淤积性肝硬化先天性胆道闭锁,并最终导致肝衰竭。已经证实,Kasai肠肠吻合术是治疗BA的有效方法。但是大多数患者仍然面临诸如胆管炎和肝纤维化的并发症。传统的草药配方“银尘四逆汤”(YCSND)被用作葛西开腹肠造口术后的BA治疗方法。并且支持YCSND可以通过多种靶标和途径改善黄疸和肝纤维化。根据已发表的文献,本研究旨在评估YCSND儿童BA的治疗现状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号